Skip to main content

Publications

featured publications

  • Emicizumab dose up-titration in case of suboptimal bleeding control in people with haemophilia A.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Christophe Schmitt, Maria Elisa Mancuso, Tiffany Chang, Maria Podolak-Dawidziak, Claire Petry, Robert Sidonio, Koichiro Yoneyama, Nigel S Key, Markus Niggli, Michaela Lehle, Flora Peyvandi, Johannes Oldenburg

  • Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B.

    The New England journal of medicine

    Authors: Johannes Oldenburg

  • Clinical experience of switching patients with severe hemophilia to rVIII-SingleChain or rIX-FP.

    Current medical research and opinion

    Authors: Johannes Oldenburg, Steven W Pipe, Maria Elisa Mancuso, Robert Klamroth, Abel Hassoun, Martin Olivieri, Georg Goldmann, Gili Kenet, Wolfgang Miesbach, Jolana Schmiedl, Inga Hegemann

  • Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1-3.

    Research and practice in thrombosis and haemostasis

    Authors: Michael U Callaghan, Elina Asikanius, Michaela Lehle, Johannes Oldenburg, Johnny Mahlangu, Marianne Uguen, Sammy Chebon, Rebecca Kruse-Jarres, Víctor Jiménez-Yuste, Midori Shima, Peter Trask, Christine L Kempton, Craig M Kessler, Gallia G Levy, Flora Peyvandi

  • Assay for ADAMTS-13 Activity with Flow Cytometric Readout.

    ACS omega

    Authors: Jens Müller, Nasim Shahidi Hamedani, Hannah L McRae, Heiko Rühl, Johannes Oldenburg, Bernd Pötzsch

  • Membrane Properties of Human Induced Pluripotent Stem Cell-Derived Cultured Red Blood Cells.

    Cells

    Authors: Claudia Bernecker, Eva Maria Matzhold, Dagmar Kolb, Afrim Avdili, Lisa Rohrhofer, Annika Lampl, Martin Trötzmüller, Heike Singer, Johannes Oldenburg, Peter Schlenke, Isabel Dorn

  • Optimization and evaluation of a two-stage chromogenic assay procedure for measurement of emicizumab plasma levels.

    PloS one

    Authors: Nasim Shahidi Hamedani, Johannes Oldenburg, Bernd Pötzsch, Jens Müller

  • Recent advances in therapeutic options for rare hemostatic disorders: selected poster extracts of recent research in hemophilia A, congenital hemophilia with inhibitors, von Willebrand disease, and thrombotic thrombocytopenic purpura presented at the …

    Expert review of hematology

    Authors: Nisha Jain, Johannes Oldenburg, Margareth C Ozelo, Shawn X Sun, Leilei Tang, Spiros Tzivelekis

  • Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors.

    Research and practice in thrombosis and haemostasis

    Authors: Claude Négrier, Johannes Oldenburg, Gili Kenet, Shannon L Meeks, Jean-Claude Bordet, Jens Müller, Sandra Le Quellec, Peter L Turecek, Nikola Tripkovic, Yesim Dargaud

  • Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors.

    Blood advances

    Authors: Amy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Hermann Eichler, Victor Jiménez-Yuste, Kaan Kavakli, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P Wheeler, Guy Young, Silva Zupančić-Šalek, Johannes Oldenburg, Pratima Chowdary